Plans feel pressure to vaccinate more adults. The cost-effectiveness of prevention is undeniable, yet vaccination rates for everything but influenza decline.
Sipkoff
Martin
M
D000328:Adult; D000368:Aged; D002487:Centers for Disease Control and Prevention, U.S.; D003362:Cost-Benefit Analysis; D006505:Hepatitis / Q000517:prevention & control; D006562:Herpes Zoster / Q000517:prevention & control; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D009980:Influenza A virus / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D008875:Middle Aged; D011315:Preventive Medicine; D014481:United States; D014612:Vaccines / Q000191:economics*
D014612:Vaccines